Overview:
Immune system of people with peanut allergy overreacts to peanut exposure, which could be severe in some cases. Most of the times, the severe allergic reaction caused due to peanuts leads to anaphylaxis, which could be fatal. It can be however treated quickly with the epinephrine which is normally administered through auto-injector. Symptoms of peanut allergy can be different in each individual, which makes it hard to diagnose the condition.
Market Drivers:
Growing initiatives taken by organizations for awareness campaigns of food allergies is expected to augment growth of the North America, Europe and Australia peanut allergy treatment market during the forecast period. For instance, Wake Country Environmental Health and Safety announced the launch of a novel campaign in December 2021 for helping residents from normal food allergens such as dairy products and nuts.
Major market players are focused on growth strategies like funding and investment for product development and preclinical studies for treatment of peanut allergy and this in turn is likely to boost growth of the North America, Europe and Australia peanut allergy treatment market during the forecast period. For instance, Moonlight Therapeutics Inc. received US$ 1.9 million funding in August 2021 for preclinical studies as well as product development so that clinical trial preparations can be started for its leading peanut allergy program.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5041
Impact of COVID-19:
After the coronavirus outbreak, many countries announced nationwide lockdown to curb the virus spread. This adversely impacted several industries around the world. As the COVID-19 cases were increasing widely all over the world, the burden on hospitals grew rapidly. Due to this, several hospitals and medical facilities suspended non-emergency medical procedures. Various approval procedures were also impacted by the pandemic, which negatively impacted growth of the North America, Europe and Australia peanut allergy treatment market. However, as the pandemic situation is going back to normal, the market is likely to regain growth.
Regional Analysis:
North America among regions is anticipated to witness substantial growth in the North America, Europe and Australia peanut allergy treatment market during the forecast period. This can be attributed to rise in availability of peanut allergy treatment products. For instance, Kaleo, announced the availability of ALLERJECT in pharmacies in Canda in May 2020.
Key Takeaways:
- North America, Europe, and Australia peanut allergy treatment market is estimated to show a CAGR of 11.7% over the forecast period. This is due to major market players are focused on partnerships. In November 2021 for instance, a pharmaceutical firm, Angany Inc. partenered with Dr. Wayne Shreffler from Massachusetts General Hospital and Mass General Hospital for Children, for preclinical studies of BP/AH-01 biological candidate for peanut allergy.
- Rise in patient admissions in several hospitals is likely to propel growth of the Hospital Pharmacies segment, among Applications in the North America, Europe and Australia peanut allergy treatment market during the forecast period. For instance, as reported by the BMJ Publishing Group Ltd. in February 2021, the number of people admitted in hospitals for anaphylaxis during 1998 to 2018 was 101,891 in the U.K. out of which 30% had food allergy.
Key Players:
Key players active in the North America, Europe and Australia peanut allergy treatment market are Stallergenes Greer Ltd., DBV Technologies, Immunomic Therapeutics, Inc., Aimmune Therapeutics, Inc., ALK, Prota Therapeutics Pty Ltd., DESENTUM OY, COUR Pharmaceuticals, Siolta Therapeutics, BlueWillow Biologics, Astellas Pharma Inc., HAL Allergy B.V., Aurobindo Pharma Limited., Allergy Therapeutics PLC., Bayer AG, Novartis AG, Sun Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Inc., Viatris Inc., Vedanta Biosciences, Inc., Johnson & Johnson, Cambridge Allergy Ltd., Sanofi, Angany Inc., Allero Therapeutics B.V., and Moonlight Therapeutics Inc.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5041
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 North America, Europe, and Australia Peanut Allergy Treatment Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: North America, Europe, and Australia Peanut Allergy Treatment Industry Impact
Chapter 2 North America, Europe, and Australia Peanut Allergy Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 North America, Europe, and Australia Peanut Allergy Treatment (Volume and Value) by Type
2.3 North America, Europe, and Australia Peanut Allergy Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 North America, Europe, and Australia Peanut Allergy Treatment Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America, Europe, and Australia Peanut Allergy Treatment Market Analysis
Chapter 6 Company Profiles and Key Figures in North America, Europe, and Australia Peanut Allergy Treatment Business
Chapter 7 North America, Europe, and Australia Peanut Allergy Treatment Market Forecast (2023-2030)
Chapter 8 Conclusions
Research Methodology
Direct Buy This Premium Research Report, Click Here Up to 25% OFF @ https://www.coherentmarketinsights.com/insight/buy-now/5041
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com